Cargando…
Ginsenoside Rh1 inhibits colorectal cancer cell migration and invasion in vitro and tumor growth in vivo
Colorectal cancer (CRC) is the third leading cause of cancer-associated mortality worldwide. Ginsenoside Rh1 (Rh1) is a traditional medicine monomer with antitumor activity; however, the effects of Rh1 in CRC remain to be determined. In the present study, SW620 cells were treated with different conc...
Autores principales: | Lyu, Xi, Xu, Xiaodong, Song, Ailin, Guo, Jinyi, Zhang, Yawu, Zhang, Youcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757309/ https://www.ncbi.nlm.nih.gov/pubmed/31579419 http://dx.doi.org/10.3892/ol.2019.10742 |
Ejemplares similares
-
20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo
por: Zhang, Haibo, et al.
Publicado: (2022) -
Ginsenoside Rh2 suppresses colon cancer growth by targeting the miR-150-3p/SRCIN1/Wnt axis: Ginsenoside Rh2 inhibits colon cancer growth via miR-150-3p/SRCIN1/Wnt
por: Li, Shipeng, et al.
Publicado: (2023) -
Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo
por: Wang, Hongbo, et al.
Publicado: (2012) -
The ways for ginsenoside Rh2 to fight against cancer: the molecular evidences in vitro and in vivo.
por: Hu, Qi-rui, et al.
Publicado: (2023) -
Increased antitumor efficacy of ginsenoside Rh(2) via mixed micelles: in vivo and in vitro evaluation
por: Xia, Xiaojing, et al.
Publicado: (2020)